Carl Zeiss Meditec AG (OTCMKTS:CZMWY) Short Interest Update

Carl Zeiss Meditec AG (OTCMKTS:CZMWY) was the target of a large increase in short interest in August. As of August 31st, there was short interest totaling 756 shares, an increase of 3,878.9% from the August 15th total of 19 shares. Based on an average trading volume of 3,423 shares, the days-to-cover ratio is currently 0.2 days.

Carl Zeiss Meditec Stock Down 2.0%

CZMWY opened at $35.15 on Friday. The firm’s fifty day simple moving average is $35.07 and its two-hundred day simple moving average is $31.73. Carl Zeiss Meditec has a 52-week low of $26.65 and a 52-week high of $55.94.

Wall Street Analyst Weigh In

CZMWY has been the subject of several recent analyst reports. Zacks Research lowered Carl Zeiss Meditec from a “hold” rating to a “strong sell” rating in a research note on Tuesday, August 11th. Morgan Stanley assumed coverage on Carl Zeiss Meditec in a research report on Wednesday, September 2nd. They set an “underweight” rating on the stock. Finally, UBS Group lowered Carl Zeiss Meditec from a “neutral” rating to a “sell” rating in a report on Tuesday, August 11th. Two research analysts have rated the stock with a Hold rating and three have given a Sell rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Strong Sell”.

About Carl Zeiss Meditec

Carl Zeiss Meditec AG is a global medical technology company headquartered in Jena, Germany. Founded in 2002 as a spin-off from the Carl Zeiss Group, the business leverages the parent company’s expertise in optics and precision engineering. Over the years, Carl Zeiss Meditec has grown through organic development and strategic acquisitions, becoming a recognized provider of innovative surgical and diagnostic solutions for eye care and microsurgery.

The company’s core offerings span two primary divisions: Ophthalmic Devices and Microsurgery.